Evidence map›Paper›PMID 33324955›Full record

ArticleHemaSphere2021

Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition.

Lorenz Thurner, Moritz Bewarder, Florian Rosar, Patrick Orth, Raoul Boris Meuter, Torben Rixecker, Vadim Lesan, Dieter Michael Kohn, Günther Schneider, Daniel Baumhoer and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Lorenz ThurnerJosé Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany.
Moritz BewarderJosé Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany.
Florian RosarInstitute of Nuclear Medicine, Saarland University Medical School, Homburg, Germany.
Patrick OrthDepartment of Orthopedics, Saarland University Medical School, Homburg, Germany.
Raoul Boris MeuterHopitaux Robert Schuman, Chimiothérapie, Oncologie, Hématologie, Luxembourg.
Torben RixeckerJosé Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany.
Vadim LesanJosé Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany.
Dieter Michael KohnDepartment of Orthopedics, Saarland University Medical School, Homburg, Germany.
Günther SchneiderDepartment of Radiology, Saarland University Medical School, Homburg, Germany.
Daniel BaumhoerBone Tumor Reference Center at the Institute for Medical Genetics and Pathology, University Hospital Basel, University of Basel, Switzerland.
Rainer Maria BohleInstitute of Pathology, Saarland University Medical School, Homburg, Germany.
Christian VeithInstitute of Pathology, Saarland University Medical School, Homburg, Germany.
Joerg Thomas BittenbringJosé Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany.
Saarland University · DEHôpital Kirchberg · LUUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33324955
PMCPMC7732267
OpenAlexW3110917316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.